About this page
Insider trades reported on SEC Form 4: when the people who run a company buy or sell its shares with their own money.
How to read it
- Form 4
- The form a company insider (officer, director or owner of more than 10%) must file with the SEC within two business days of buying or selling the company's shares.
- Buy (P) and Sell (S)
- Open-market purchases and sales. Gifts, option exercises and automatic tax withholding are left out because they say little about what the insider thinks.
- Value
- Shares times price, as reported on the filing.
- 10b5-1
- A trade made under a plan set up in advance. Planned sales are common and usually say less than an unplanned purchase.
- Late filing
- A Form 4 filed more than two business days after the trade.
- Vs. S&P 500
- How the stock did after the trade minus how the overall market did in the same weeks.
A real example
In January 2016, when bank stocks were falling, JPMorgan Chase CEO Jamie Dimon bought 500,000 JPMorgan shares with his own money, worth about $26 million. His Form 4 made the purchase public within days, and investors read it as a strong sign of confidence.
Explain it like I'm 13
If the coach of a team bets his own allowance that his team will win, that tells you something. A Form 4 is the note a company boss must hand in whenever he buys or sells his own company's shares, so everyone can see it.
Data from public SEC filings and congressional reports. Information, not investment advice. Check every number against the filing linked on the page.
Travere Therapeutics, Inc. (TVTX): Insider Trades and Fund Holdings
In the past 12 months, Travere Therapeutics, Inc. insiders reported no open-market purchases and 19 sales worth $80.9M; 18 of the sales were reported as made under a 10b5-1 trading plan.
Timeline: news and trades
Company filings (8-K), insider trades, notices of planned sales (Form 144), Congress trades and fund moves in the past year, newest first.
- Oct 15, 2026Insider saleCEO Eric M. Dube sold $13.1 million under a 10b5-1 plan
- Oct 15, 2026Planned saleERIC DUBE (director, officer) filed notice to sell about $13 million around Oct 15, 2026
- Sep 21, 2026NewsCompany reported: Executive or director change
- Sep 17, 2026Insider saleCEO Eric M. Dube sold $7 million under a 10b5-1 plan
- Sep 17, 2026Insider saleEVP Peter Heerma sold $538,917 under a 10b5-1 plan
- Sep 17, 2026Planned saleERIC DUBE (director, officer) filed notice to sell about $6.9 million around Sep 17, 2026
- Sep 17, 2026Planned salePETER HEERMA (officer) filed notice to sell about $525,741 around Sep 17, 2026
- Sep 16, 2026Insider saleCEO Eric M. Dube sold $12.4 million under a 10b5-1 plan
- Sep 16, 2026Insider saleEVP Peter Heerma sold $11 million under a 10b5-1 plan
- Sep 16, 2026Insider saleChief Research Officer William E. Rote sold $7.1 million under a 10b5-1 plan
- Sep 16, 2026Planned saleERIC DUBE (director, officer) filed notice to sell about $12.2 million around Sep 16, 2026
- Sep 16, 2026Planned salePETER HEERMA (officer) filed notice to sell about $10.8 million around Sep 16, 2026
- Sep 16, 2026Planned saleWILLIAM ROTE (officer) filed notice to sell about $7.1 million around Sep 16, 2026
- Sep 15, 2026Insider saleEVP Peter Heerma sold $6.4 million under a 10b5-1 plan
- Sep 15, 2026Insider saleChief Research Officer William E. Rote sold $6 million under a 10b5-1 plan
- Sep 15, 2026Insider saleCEO Eric M. Dube sold $6 million under a 10b5-1 plan
- Sep 15, 2026Insider saleCFO Christopher R. Cline sold $3.1 million under a 10b5-1 plan
- Sep 15, 2026Insider saleEVP Jula Inrig sold $2.8 million under a 10b5-1 plan
- Sep 15, 2026Insider saleGeneral Counsel Elizabeth E. Reed sold $2.3 million under a 10b5-1 plan
- Sep 15, 2026Insider saleCAO Sandra Calvin sold $335,004 under a 10b5-1 plan
- Sep 15, 2026Planned salePETER HEERMA (officer) filed notice to sell about $6.7 million around Sep 15, 2026
- Sep 15, 2026Planned saleWILLIAM ROTE (officer) filed notice to sell about $6.3 million around Sep 15, 2026
- Sep 15, 2026Planned saleERIC DUBE (director, officer) filed notice to sell about $6.3 million around Sep 15, 2026
- Sep 15, 2026Planned saleCHRISTOPHER CLINE (officer) filed notice to sell about $3.3 million around Sep 15, 2026
- Sep 15, 2026Planned saleJULA INRIG (officer) filed notice to sell about $2.9 million around Sep 15, 2026
- Sep 15, 2026Planned saleELIZABETH REED (officer) filed notice to sell about $2.6 million around Sep 15, 2026
- Sep 15, 2026Planned saleSANDRA CALVIN (officer) filed notice to sell about $353,621 around Sep 15, 2026
- Sep 10, 2026Insider saleDirector Jeffrey A. Meckler sold $1.3 million under a 10b5-1 plan
- Sep 10, 2026Planned saleJEFFREY MECKLER (director) filed notice to sell about $1.3 million around Sep 10, 2026
- Sep 2, 2026Insider saleCFO Christopher R. Cline sold $42,610
- Aug 18, 2026Insider saleDirector Gary A. Lyons sold $316,860 under a 10b5-1 plan
- Aug 18, 2026Planned saleGARY LYONS (director) filed notice to sell about $317,650 around Aug 18, 2026
- Aug 17, 2026Insider saleDirector Gary A. Lyons sold $315,986 under a 10b5-1 plan
- Aug 17, 2026Planned saleGARY A LYONS (director) filed notice to sell about $310,700 around Aug 17, 2026
- Jun 30, 2026FundRenaissance Technologies cut 7% in Q2 2026 (13F filed Aug 13, 2026)
- Jun 12, 2026Insider saleDirector Timothy Coughlin sold $500,747 under a 10b5-1 plan
- Jun 12, 2026Insider saleDirector Roy D. Baynes sold $225,000 under a 10b5-1 plan
Recent insider trades
Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Oct 19, 2026.
| Filed | Insider | Type | Value |
|---|---|---|---|
| Oct 19 | Eric M. DubeCEO | ▼ SELL10b5-1 | $13.1M |
| Sep 17 | Eric M. DubeCEO | ▼ SELL10b5-1 | $12.4M |
| Sep 17 | Peter HeermaEVP | ▼ SELL10b5-1 | $11.0M |
| Sep 17 | William E. RoteChief Research Officer | ▼ SELL10b5-1 | $7.15M |
| Sep 17 | Eric M. DubeCEO | ▼ SELL10b5-1 | $7.01M |
| Sep 17 | Peter HeermaEVP | ▼ SELL10b5-1 | $6.36M |
| Sep 17 | William E. RoteChief Research Officer | ▼ SELL10b5-1 | $5.99M |
| Sep 17 | Eric M. DubeCEO | ▼ SELL10b5-1 | $5.96M |
| Sep 17 | Christopher R. ClineCFO | ▼ SELL10b5-1 | $3.15M |
| Sep 17 | Jula InrigEVP | ▼ SELL10b5-1 | $2.79M |
Insiders who traded in the past year
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Eric M. Dube | CEO | 0 | $0 | 4 | $38.5M |
| Peter Heerma | EVP | 0 | $0 | 3 | $17.9M |
| William E. Rote | Chief Research Officer | 0 | $0 | 2 | $13.1M |
| Christopher R. Cline | CFO | 0 | $0 | 2 | $3.19M |
| Jula Inrig | EVP | 0 | $0 | 1 | $2.79M |
| Elizabeth E. Reed | General Counsel | 0 | $0 | 1 | $2.34M |
| Sandra Calvin | CAO | 0 | $0 | 1 | $335K |
| Jeffrey A. Meckler | Director | 0 | $0 | 1 | $1.35M |
Buybacks and executive pay
| Year | CEO pay reported | CEO pay "actually paid" | Value of $100 invested |
|---|---|---|---|
| 2025 | $8.46M | $24.5M | n/a |
| 2024 | $5.20M | $10.9M | n/a |
| 2023 | $7.57M | $885K | n/a |
From the company's XBRL data filed with the SEC. "Actually paid" is the SEC's pay-versus-performance measure, which counts changes in the value of stock awards. "Value of $100 invested" is the company's cumulative shareholder return as reported, usually measured from five years earlier. See all buybacks and CEO pay across companies.
A All 19 insider trades reported on time. How it is graded
Tracked funds that report TVTX
From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.
| Fund | Shares | Value | Change |
|---|---|---|---|
| Renaissance Technologies | 1,833,079 | $104.1M | ▼ −6.8% |
Reading these numbers
Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →